Was hoping for at least $2.2 but $2.1 is a massive change from last year and will take this as enough of a turnaround (about $2.5m I think) to stay on board. They have $2.4 in the bank and no debt which is a good sign.
Interesting the comment about the COVID having no effect.
At $2.1 this gives a current P/E of around 8 when everything else in this space seems to be in the 15-30 P/E range.
This still represents CCG as being undervalued compared to market and I think it may head up if their strategies pay off. Will be interesting to see what they forecast for next FY. I think they need to do at least 2 M&As to get the right attention.
Interesting to see if they get any attention from the likes of UWL and ST1 who have been active with M&A.
Made me go back and look at other stocks in this space and compare P/Es.
MNF P/E 30+
OTW 30+
VOC 17
TEL 18
5G No P/E
Vonex No P/E
ST1 No P/E
MAQ 60+
UWL 30+
OPC 20+
Peter McGrath looks to be earning his salary. I still think John McKay is not a good look even though he would get some credit here.
- Forums
- ASX - By Stock
- CCG
- Ann: FY20 market guidance and business update
Ann: FY20 market guidance and business update, page-2
Featured News
Add CCG (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.6¢ |
Change
0.004(5.56%) |
Mkt cap ! $29.46M |
Open | High | Low | Value | Volume |
7.5¢ | 7.6¢ | 7.5¢ | $5.645K | 74.31K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 7.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.6¢ | 147847 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.072 |
1 | 50000 | 0.071 |
2 | 114011 | 0.070 |
1 | 10000 | 0.050 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.076 | 147847 | 2 |
0.078 | 400000 | 1 |
0.081 | 60739 | 1 |
0.082 | 463740 | 2 |
0.088 | 217312 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
CCG (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online